According to Immunovant, the medicine, batoclimab, succeeded in a Phase 3 study of patients with myasthenia gravis and the first part of a Phase 2b trial focused on an immune condition that damages ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR antibodies), ...

Generalised myasthenia gravis (gMG) is a chronic disorder in which the body's immune system mistakenly targets the neuromuscular junctions—areas where nerves signal muscles to move. This ...

One such is myasthenia gravis (MG), an autoimmune neuromuscular disorder that causes weakness in the ... Speech and swallowing therapy assists those with bulbar symptoms, preventing aspiration and ...